http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2002526780-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-74 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
| filingDate | 1999-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2002-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2002526780-A |
| titleOfInvention | How to determine a predisposition to leptin treatment |
| abstract | (57) [Summary]nA low baseline of serum leptin levels is used to predict whether or to what extent an individual will be able to respond to leptin administration. Disclosed are methods and related compositions based on the determination of whether the bottom approximately 25% of selected obese populations have baseline serum leptin levels. |
| priorityDate | 1998-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 156.